MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus

Mesenchymal stem cells (MSCs) are identified as a promising tool for the treatment of autoimmune diseases, and several microRNAs (miRNAs) are shown to exhibit vital roles in immune diseases. However, their function and mechanism in systemic lupus erythematosus (SLE) is still unclear. The qRT-PCR ana...

Full description

Bibliographic Details
Main Authors: Dan Li, Xiaoqing Li, Mingyue Duan, Yufeng Dou, Yuan Feng, Nan Nan, Wanggang Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2020-05-01
Series:Autoimmunity
Subjects:
Online Access:http://dx.doi.org/10.1080/08916934.2020.1750011